The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets.

PubWeight™: 2.04‹?› | Rank: Top 2%

🔗 View Article (PMC 1176554)

Published in Biochem J on January 01, 1971

Authors

D C Mills, J B Smith

Articles citing this

An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A (1990) 3.98

Two distinct adenosine-sensitive sites on adenylate cyclase. Proc Natl Acad Sci U S A (1977) 3.89

The mechanism of adenosine diphosphate induced platelet aggregation: binding to platelet receptors and inhibition of binding and aggregation by prostaglandin E 1 . J Physiol (1972) 2.05

13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor. Proc Natl Acad Sci U S A (1979) 1.33

Isolation of intact megakaryocytes from guinea pig femoral marrow. Successful harvest made possible with inhibitions of platelet aggregation; enrichment achieved with a two-step separation technique. J Cell Biol (1976) 1.28

Lysophosphatidic acids. Influence on platelet aggregation and intracellular calcium flux. Am J Pathol (1979) 1.18

Adenosine release from stimulated mast cells. Proc Natl Acad Sci U S A (1984) 1.11

Translational therapeutics of dipyridamole. Arterioscler Thromb Vasc Biol (2008) 1.09

Anti-platelet therapy: phosphodiesterase inhibitors. Br J Clin Pharmacol (2011) 1.03

The interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time. Br J Clin Pharmacol (1979) 1.03

Membrane changes during cartilage maturation. Increase in 5'-nucleotidase and decrease in adenosine inhibition of adenylate cyclase. J Cell Biol (1977) 1.02

Effects of catecholamines on the formation of adenosine 3':5'-cyclic monophosphate in human blood platelets. Biochem J (1971) 0.96

Platelet beta-adrenoceptors. Br J Pharmacol (1983) 0.90

Mammalian platelet adrenoceptors. Br J Pharmacol (1984) 0.89

The influence of prostaglandin G2 on platelet ultrastructure and platelet secretion. Am J Pathol (1977) 0.85

The prostanoids in hemostasis and thrombosis: a review. Am J Pathol (1980) 0.83

Binding of dipyridamole to human platelets and to alpha1 acid glycoprotein and its significance for the inhibition of adenosine uptake. J Clin Invest (1977) 0.83

Prostaglandin I2 (prostacyclin). Can Med Assoc J (1980) 0.82

Prostaglandin E1 and forskolin antagonize C-kinase activation in the human platelet. Biochem J (1987) 0.80

Effects of cAMP modulators on long-chain fatty-acid uptake and utilization by electrically stimulated rat cardiac myocytes. Biochem J (2002) 0.79

Dipyridamole increases red cell deformability. Br J Clin Pharmacol (1983) 0.79

Thrombin-induced increase in intracellular cyclic 3',5'-adenosine monophosphate in human platelets. J Clin Invest (1972) 0.79

Differential inhibition by adenosine or by prostaglandin E1 of human platelet aggregation induced by adenosine 5'-O-(1-thiodiphosphate) and adenosine 5'-O-(2-thiodiphosphate). Br J Pharmacol (1982) 0.79

A simple assay for adenylate cyclase in intact cells by affinity elution chromatography. Biochem J (1978) 0.78

Extracellular adenosine levels are associated with the progression and exacerbation of pulmonary fibrosis. FASEB J (2015) 0.77

Effect of dipyridamole on the formation of 6-oxo-prostaglandin F1 alpha by the rat isolated aorta and ram seminal vesicle microsomes. Br J Pharmacol (1982) 0.77

Dipyridamole: pharmacokinetics and effects on aspects of platelet function in man. Br J Clin Pharmacol (1987) 0.77

Adenosine-induced release of cyclic adenosine 3',5'-monophosphate from the left ventricle in the anaesthetized intact dog. J Physiol (1978) 0.75

Comparison of the effects of drugs on the aggregation of hamster platelets in vivo and in vitro. Br J Pharmacol (1971) 0.75

In vivo interaction of prostacyclin with an inhibitor of cyclic nucleotide phosphodiesterase, HL 725. Br J Pharmacol (1985) 0.75

Historical perspective on ADP-induced platelet activation. Purinergic Signal (2011) 0.75

In vitro inhibition of platelet function and coagulation by pentamidine isethionate. Antimicrob Agents Chemother (1977) 0.75

Articles cited by this

Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature (1962) 18.89

A simple, sensitive method for the assay of adenyl cyclase. J Pharmacol Exp Ther (1968) 8.05

The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices. Mol Pharmacol (1970) 5.15

Effects of adrenaline on human blood platelets. J Physiol (1967) 2.38

Platelet aggregation. I. Regulation by cyclic AMP and prostaglandin E1. Biochem Biophys Res Commun (1969) 1.89

Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo. Br Med J (1967) 1.85

Adenyl cyclase activity in human platelets. Biochem Biophys Res Commun (1969) 1.84

Cyclic 3',5'-adenosine monophosphate in human blood platelets. Nature (1969) 1.40

A new scintillator for liquid scintillation counting. Int J Appl Radiat Isot (1967) 1.35

Adenyl cyclase in human platelets: activity and responsiveness. Biochem Biophys Res Commun (1969) 1.26

Platelet aggregation. II. Adenyl cyclase, prostaglandin E1, and calcium. Biochem Biophys Res Commun (1969) 1.25

Blood platelet nucleotides in man and other species. Nature (1969) 1.24

Detection and determination of adenosine diphosphate and related substances in plasma. Biochem J (1966) 1.20

STRONG INHIBITION BY 2-CHLOROADENOSINE OF THE AGGREGATION OF BLOOD PLATELETS BY ADENOSINE DIPHOSPHATE. Nature (1964) 1.14

Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate. Biochem J (1970) 1.13

Effect of some inhibitors of platelet aggregation on platelet nucleotides. Biochem J (1969) 1.08

Beta-adrenergic receptors in human platelets. J Atheroscler Res (1969) 1.07

Inhibition and reversal of platelet aggregation by methyl xanthines. Thromb Diath Haemorrh (1967) 0.99

Inhibition of rat liver adenyl cyclase by adenosine and adenine nucleotides. Experientia (1970) 0.99

Adenine nucleotide metabolism of blood platelets. II. Uptake of adenosine and inhibition of ADP-induced platelet aggregation. Biochim Biophys Acta (1968) 0.98

Effect of adenine compounds on platelet aggregation. Am J Physiol (1969) 0.96

Powerful new aggregator of blood platelets--2-chloroadenosine-5'-diphosphate. Nature (1968) 0.95

Kinetic studies of platelet aggregation induced by adenosine diphosphate and its inhibition by chelating agents, guanidino compounds, and adenosine. Thromb Diath Haemorrh (1967) 0.91

Platelet volume: effect of temperature and agents affecting platelet aggregation. Am J Physiol (1969) 0.87

[Influence of cardio- and vasoactive substances on phosphodiesterase activity]. Naunyn Schmiedebergs Arch Pharmakol (1969) 0.86

[Studies on the influence of papaverine on reactions of the blood platelets]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 0.84

Inhibition of 3'5'-cyclic-AMP phosphodiesterase by some platelet aggregation inhibitors. Biochem Pharmacol (1970) 0.83

Articles by these authors

(truncated to the top 100)

Nuclear dna amounts in angiosperms. Philos Trans R Soc Lond B Biol Sci (1976) 10.59

Antibody formation by single cells from lymph nodes and efferent lymph of sheep. J Exp Med (1966) 8.86

Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol (1971) 7.75

Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med (1998) 4.08

Genome size and the proportion of repeated nucleotide sequence DNA in plants. Biochem Genet (1974) 3.66

Metabolism of [14C]arachidonic acid by human platelets. Biochim Biophys Acta (1976) 2.61

Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction. Anal Biochem (2000) 2.53

Effects of adrenaline on human blood platelets. J Physiol (1967) 2.38

Prostaglandin D2 inhibits the aggregation of human platelets. Thromb Res (1974) 2.35

Serum stimulates the Na+,K+ pump in quiescent fibroblasts by increasing Na+ entry. Proc Natl Acad Sci U S A (1978) 2.29

The traffic of cells through tissues: a study of peripheral lymph in sheep. J Anat (1970) 2.24

The major in vivo modifications of the human water-insoluble lens crystallins are disulfide bonds, deamidation, methionine oxidation and backbone cleavage. Exp Eye Res (2000) 2.10

Japanese yew poisoning of large domestic animals in the Midwest. J Am Vet Med Assoc (1977) 2.07

Perirenal edema and toxic nephrosis in cattle, associated with ingestion of pigweed. J Am Vet Med Assoc (1975) 2.04

The release of nucleotides, 5-hydroxytryptamine and enzymes from human blood platelets during aggregation. J Physiol (1968) 1.97

Formation of prostaglandins during the aggregation of human blood platelets. J Clin Invest (1973) 1.96

Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem (1998) 1.93

The migration of cells through chronically inflamed tissues. J Pathol (1970) 1.92

Arachidonic acid causes sudden death in rabbits. Science (1974) 1.91

Activation of suppressor T cells in human autologous mixed lymphocyte culture. J Immunol (1979) 1.90

Age-related changes in human lens crystallins identified by two-dimensional electrophoresis and mass spectrometry. Exp Eye Res (1998) 1.88

The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation. Blood (1975) 1.87

Malondialdehyde formation as an indicator of prostaglandin production by human platelets. J Lab Clin Med (1976) 1.86

Sequence analysis of betaA3, betaB3, and betaA4 crystallins completes the identification of the major proteins in young human lens. J Biol Chem (1997) 1.84

Selective release of archidonic acid from the phospholipids of human platelets in response to thrombin. J Clin Invest (1977) 1.84

Reevaluation of ampicillin therapy for Hemophilus influenzae meningitis. An appraisal based on a review of cases of persistent or recurrent infection. Am J Dis Child (1971) 1.82

Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil. Clin Cancer Res (1999) 1.82

Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction. J Clin Invest (1974) 1.76

Arachidonic acid-induced human platelet aggregation and prostaglandin formation. Prostaglandins (1973) 1.69

The murine neutrophil-chemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue-specific sensitivities to glucocorticoid regulation in endotoxemia. J Leukoc Biol (1998) 1.67

Syngeneic mixed lymphocyte reaction in mice: strain distribution, kinetics, participating cells, and absence in NZB mice. J Immunol (1978) 1.67

Ischemia-reperfusion of rat myocardium activates nuclear factor-KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation (2001) 1.63

Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. Science (1978) 1.62

Formation and release of prostaglandins by platelets in response to thrombin. Br J Pharmacol (1970) 1.59

Carbodiimide-resistant membrane adenosine triphosphatase in mutants of Streptococcus faecalis. I. Studies of the mechanism of resistance. J Biol Chem (1972) 1.58

Bovine endothelial cells in culture produce thromboxane as well as prostacyclin. J Clin Invest (1981) 1.58

Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature. Circulation (1980) 1.56

Metabolism and function of human platelets washed by albumin density gradient separation. Br J Haematol (1977) 1.56

Age-related changes in human lens crystallins identified by HPLC and mass spectrometry. Exp Eye Res (1998) 1.53

Post-translational modifications of water-soluble human lens crystallins from young adults. J Biol Chem (1994) 1.53

Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Proc Natl Acad Sci U S A (1980) 1.52

Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60. Proc Natl Acad Sci U S A (1986) 1.51

Purification of membrane attachment and inhibitory subunits of the proton translocating adenosine triphosphatase from Escherichia coli. Biochemistry (1977) 1.49

Studies on the protective effect of prostacyclin in acute myocardial ischemia. Eur J Pharmacol (1979) 1.47

Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation. Proc Natl Acad Sci U S A (1979) 1.47

Selective binding site for [3H]prostacyclin on platelets. J Clin Invest (1979) 1.47

Identification of possible regions of chaperone activity in lens alpha-crystallin. Exp Eye Res (1996) 1.46

Intraintestinal toxin in infant mice challenged intragastrically with Clostridium botulinum spores. Infect Immun (1978) 1.42

Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence. J Clin Invest (1979) 1.39

Duration of inhibition of platelet prostaglandin formation and aggregation by ingested aspirin or indomethacin. Prostaglandins (1973) 1.39

Stress and developmental regulation of the yeast C-type cyclin Ume3p (Srb11p/Ssn8p). EMBO J (1997) 1.35

Human blood prostaglandins: formation during clotting. Prostaglandins (1972) 1.35

Formation of lysophosphatidylcholine by human platelets in response to thrombin. Support for the phospholipase A2 pathway for the liberation of arachidonic acid. J Biol Chem (1981) 1.34

Immunologic studies in chronic lymphocytic leukemia: defective stimulation of T-cell proliferation in autologous mixed lymphocyte culture. J Natl Cancer Inst (1977) 1.34

Stimulation of autologous and allogeneic human T cells by B cells occurs through separate B-cell antigen systems. Cell Immunol (1978) 1.33

Deamidation and disulfide bonding in human lens gamma-crystallins. Exp Eye Res (1998) 1.31

Temperature and nucleotide dependence of calcium release by myo-inositol 1,4,5-trisphosphate in cultured vascular smooth muscle cells. J Biol Chem (1985) 1.30

Modifications of the water-insoluble human lens alpha-crystallins. Exp Eye Res (1996) 1.30

Cytogenetics of fetal abortions. Pediatrics (1967) 1.29

Stimulation of human platelet adenylate cyclase by prostaglandin D2. Thromb Res (1974) 1.26

Size of human lens beta-crystallin aggregates are distinguished by N-terminal truncation of betaB1. J Biol Chem (1997) 1.25

The role of the lymphatic system and lymphoid cells in the establishment of immunological memory. Aust J Exp Biol Med Sci (1970) 1.24

Blood platelet nucleotides in man and other species. Nature (1969) 1.24

Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin. Mol Pharmacol (1982) 1.23

Use of a radioimmunoassay to study thrombin-induced release of PGI2 from cultured endothelium. Thromb Res (1979) 1.22

Malignant peripheral nerve sheath tumor (malignant schwannoma) of urinary bladder in von Recklinghausen neurofibromatosis. Urology (1991) 1.20

Detection and determination of adenosine diphosphate and related substances in plasma. Biochem J (1966) 1.20

Viral hepatitis, postnecrotic cirrhosis, and hepatocellular carcinoma. Lancet (1969) 1.20

Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum (1987) 1.19

Ubiquitination of protein kinase C-alpha and degradation by the proteasome. J Biol Chem (1996) 1.19

The response of the popliteal lymph node of the sheep to swine influenza virus. Aust J Exp Biol Med Sci (1970) 1.18

Lithium transport by fibroblastic mouse cells: characterization and stimulation by serum and growth factors in quiescent cultures. J Cell Physiol (1978) 1.17

The sequence of human betaB1-crystallin cDNA allows mass spectrometric detection of betaB1 protein missing portions of its N-terminal extension. J Biol Chem (1996) 1.17

The platelet defect associated with albumism. Br J Haematol (1972) 1.17

Hereditary giant platelet syndrome. Absence of collagen-induced coagulant activity and deficiency of factor-XI binding to platelets. Br J Haematol (1975) 1.16

Activation of atypical protein kinase C zeta by caspase processing and degradation by the ubiquitin-proteasome system. J Biol Chem (2000) 1.15

Analysis of angiotensin-stimulated sodium transport in cultured smooth muscle cells from rat aorta. J Cell Physiol (1983) 1.15

Antibodies to phospholipids and nuclear antigens in patients with repeated abortions. Am J Obstet Gynecol (1986) 1.15

Angiotensin II rapidly increases phosphatidate-phosphoinositide synthesis and phosphoinositide hydrolysis and mobilizes intracellular calcium in cultured arterial muscle cells. Proc Natl Acad Sci U S A (1984) 1.14

Cathepsin G is a strong platelet agonist released by neutrophils. Biochem J (1988) 1.14

In vivo carbamylation and acetylation of water-soluble human lens alphaB-crystallin lysine 92. Protein Sci (2001) 1.13

Human lymphocyte responses are enhanced by culture at 40 degrees C. J Immunol (1978) 1.13

Bryostatins: potent, new mitogens that mimic phorbol ester tumor promoters. Biochem Biophys Res Commun (1985) 1.13

Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal's angina. Prostaglandins Med (1979) 1.11

Leptomeningeal carcinomatosis: a sequela of cholangiocarcinoma. Am Surg (1997) 1.11

Hordeum and Secale mitotic genomes lie apart in a hybrid. J Cell Sci (1981) 1.11

Antibodies which antagonise the effects of prostacyclin. Nature (1978) 1.10

Oligomerization and phase separation in globular protein solutions. Biophys Chem (1998) 1.10

Evidence for a role for tyrosine phosphorylation of phospholipase C gamma 2 in collagen-induced platelet cytosolic calcium mobilization. Biochem J (1994) 1.10

Characterization of the inhibitory (epsilon) subunit of the proton-translocating adenosine triphosphatase from Escherichia coli. Biochemistry (1980) 1.09

Platelets and the vessel wall: how much aspirin? Lancet (1980) 1.09

The adenylate kinase of human plasma, erythrocytes and platelets in relation to the degradation of adenosine diphosphate in plasma. Biochem J (1967) 1.09

Bryostatin 1 and phorbol ester down-modulate protein kinase C-alpha and -epsilon via the ubiquitin/proteasome pathway in human fibroblasts. Mol Pharmacol (1997) 1.09

Two temporal parameters of food postponement. J Exp Anal Behav (1972) 1.08

Formation and metabolism of inositol 1,4,5-trisphosphate in human platelets. Biochem J (1987) 1.08

Human lens beta-crystallin solubility. J Biol Chem (2000) 1.07

2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets. J Clin Invest (1983) 1.07

Significance of self-recognition and interleukin-2 for immunoregulation, autoimmunity and cancer. Scand J Immunol (1982) 1.07

Finding sutures. Plast Reconstr Surg (1989) 1.07

A method for electron microscopic examination of antibody-producing cells. Immunology (1966) 1.06